TESTOSTERONE | A080911 | ENDO OPERATIONS LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Actient Pharmaceuticals - Citizen Petition FDA-2012-P-0737 · 4 docket documents Actient Pharmaceuticals LLC filed this citizen petition under 21 USC 355 and 21 CFR 10.30 on July 9, 2012, requesting that the FDA refrain from approving any abbreviated new drug application (ANDA) referencing Testopel Pellets (testosterone) for subcutaneous implantation without requiring sponsors t | 505(q) | 2012-07-12 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.